CORRESP Filing
AIM ImmunoTech Inc.
Date: July 24, 2025 · CIK: 0000946644 · Accession: 0001493152-25-011378
AI Filing Summary & Sentiment
File numbers found in text: 333-284443
Show Raw Text
CORRESP 1 filename1.htm July 24, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-1004 Re: AIM ImmunoTech Inc. Registration Statement on Form S-1, as amended File No. 333-284443 Ladies and Gentlemen: As the placement agent of the proposed offering of AIM ImmunoTech Inc. (the "Company"), we hereby join the Company's request for acceleration of the above-referenced Registration Statement, requesting effectiveness for 5:00 p.m., Eastern Time, on Monday, July 28, 2025, or as soon thereafter as is practicable. Pursuant to Rule 460 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, we wish to advise you that, through July 24, 2025, we distributed to each dealer, who is reasonably anticipated to be invited to participate in the distribution of the security, as many copies, as well as "E-red" copies of the Preliminary Prospectus dated July 22, 2025, as appears to be reasonable to secure adequate distribution of the preliminary prospectus. The undersigned advise that they have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. Very truly yours, Maxim Group LLC By: /s/ Ritesh Veera Name: Ritesh Veera Title: Co-Head of Investment Banking